Literature DB >> 24379595

Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China.

Su-Wen Li1, Kai Wang1, Yong-Qiang Yu1, Hai-Bao Wang1, Yuan-Hai Li1, Jian-Ming Xu1.   

Abstract

AIM: To construct normal values for the tests of the psychometric hepatic encephalopathy score (PHES) and to evaluate its usefulness in the diagnosis of minimal hepatic encephalopathy (MHE) among Chinese individuals with cirrhosis.
METHODS: The five tests of PHES, number connection test-A (NCT-A), number connection test-B, serial dotting test, line tracing test and digit symbol test (DST), were administered to all enrolled subjects in a quiet room with sufficient light. Cirrhotic subjects with overt HE were excluded by the West-Haven criteria and a detailed neurological examination. Based on the nomograms of healthy volunteers, the patients were classified as having MHE when their PHES was less than -4.
RESULTS: In total, 146 healthy volunteers completed all the PHES tests. Age and education years were confirmed to be predictors of all five tests. In total, 53 patients with liver cirrhosis completed the PHES. Of the patients with liver cirrhosis, 24 (45.3%), 22(41.5%) and 7(13.2%) had Child-Pugh grades A, B and C, respectively. MHE was diagnosed in 26 patients (49.1%). Compared with compensated cirrhotic patients (Child A), decompensated cirrhotic patients (Child B and C) had a higher proportion of MHE (65.5% vs 29.2%). No differences in age and education years were found between the MHE and non-MHE groups. NCT-A and DST were able to diagnose MHE with a sensitivity of 76.9% and a specificity of 96.3% (AUC = 0.866, K = 0.735).
CONCLUSION: The proportion of MHE is associated with liver function. NCT-A and DST are simple tools that can be used for the diagnosis of MHE in China.

Entities:  

Keywords:  Cirrhosis; Digit symbol test; Minimal hepatic encephalopathy; Neuropsychological tests; Number connection test; Psychometric hepatic encephalopathy score

Mesh:

Year:  2013        PMID: 24379595      PMCID: PMC3870523          DOI: 10.3748/wjg.v19.i46.8745

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

Review 1.  Neuropsychological characterization of hepatic encephalopathy.

Authors:  K Weissenborn; J C Ennen; H Schomerus; N Rückert; H Hecker
Journal:  J Hepatol       Date:  2001-05       Impact factor: 25.083

2.  Testing for minimal hepatic encephalopathy in the United States: An AASLD survey.

Authors:  Jasmohan Singh Bajaj; Ashkan Etemadian; Muhammad Hafeezullah; Kia Saeian
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

3.  Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Kia Saeian; Matthew D Verber; Darrell Hischke; Raymond G Hoffmann; Jose Franco; Rajiv R Varma; Stephen M Rao
Journal:  Am J Gastroenterol       Date:  2007-01-11       Impact factor: 10.864

4.  Critical flicker frequency: it is time to break down barriers surrounding minimal hepatic encephalopathy.

Authors:  Manuel Romero-Gómez
Journal:  J Hepatol       Date:  2007-04-20       Impact factor: 25.083

5.  Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy.

Authors:  A H Lockwood; E W Yap; W H Wong
Journal:  J Cereb Blood Flow Metab       Date:  1991-03       Impact factor: 6.200

6.  Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy.

Authors:  Srinivasa Prasad; Radha K Dhiman; Ajay Duseja; Yogesh K Chawla; Arpita Sharma; Ritesh Agarwal
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

7.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

8.  The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Leroy R Thacker; Douglas M Heuman; Michael Fuchs; Richard K Sterling; Arun J Sanyal; Puneet Puri; Mohammad S Siddiqui; Richard T Stravitz; Iliana Bouneva; Velimir Luketic; Nicole Noble; Melanie B White; Pamela Monteith; Ariel Unser; James B Wade
Journal:  Hepatology       Date:  2013-05-23       Impact factor: 17.425

9.  Value of the critical flicker frequency in patients with minimal hepatic encephalopathy.

Authors:  Manuel Romero-Gómez; Juan Córdoba; Rodrigo Jover; Juan A del Olmo; Marta Ramírez; Ramón Rey; Enrique de Madaria; Carmina Montoliu; David Nuñez; Montse Flavia; Luis Compañy; José M Rodrigo; Vicente Felipo
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

10.  Correlation between ammonia levels and the severity of hepatic encephalopathy.

Authors:  Janus P Ong; Anjana Aggarwal; Derk Krieger; Kirk A Easley; Matthew T Karafa; Frederick Van Lente; Alejandro C Arroliga; Kevin D Mullen
Journal:  Am J Med       Date:  2003-02-15       Impact factor: 4.965

View more
  23 in total

Review 1.  Advances in psychometric tests for screening minimal hepatic encephalopathy: From paper-and-pencil to computer-aided assessment.

Authors:  Ming Luo; Ping Ma; Lei Li; Wu-Kui Cao
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

2.  Identification of minimal hepatic encephalopathy based on dynamic functional connectivity.

Authors:  Yue Cheng; Gaoyan Zhang; Xiaodong Zhang; Yuexuan Li; Jingli Li; Jiamin Zhou; Lixiang Huang; Shuangshuang Xie; Wen Shen
Journal:  Brain Imaging Behav       Date:  2021-03-23       Impact factor: 3.978

3.  Interferon gamma, interleukin-6, and -17a levels were correlated with minimal hepatic encephalopathy in HBV patients.

Authors:  Wei Li; Ning Li; Rui Wang; Qunhui Li; Hao Wu
Journal:  Hepatol Int       Date:  2015-03-21       Impact factor: 6.047

4.  Minimal hepatic encephalopathy characterized by parallel use of the continuous reaction time and portosystemic encephalopathy tests.

Authors:  M M Lauridsen; O B Schaffalitzky de Muckadell; H Vilstrup
Journal:  Metab Brain Dis       Date:  2015-05-29       Impact factor: 3.584

Review 5.  A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Hepatic Encephalopathy and Clostridioides difficile Infection in Patients With Cirrhosis.

Authors:  Kyaw Min Tun; Annie S Hong; Kavita Batra; Yassin Naga; Gordon Ohning
Journal:  Cureus       Date:  2022-05-31

6.  Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES).

Authors:  Mircea Alexandru Badea; Vasile Liviu Drug; Mihaela Dranga; Otilia Gavrilescu; Gabriela Stefanescu; Iolanda Popa; Catalina Mihai; Cristina Cijevschi-Prelipcean
Journal:  Metab Brain Dis       Date:  2016-07-27       Impact factor: 3.584

7.  Identifying minimal hepatic encephalopathy in cirrhotic patients by measuring spontaneous brain activity.

Authors:  Hua-Jun Chen; Ling Zhang; Long-Feng Jiang; Qiu-Feng Chen; Jun Li; Hai-Bin Shi
Journal:  Metab Brain Dis       Date:  2016-02-17       Impact factor: 3.584

8.  Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients.

Authors:  Fu-Liang He; Lei Wang; Zhen-Dong Yue; Hong-Wei Zhao; Fu-Quan Liu
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

9.  Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients.

Authors:  Ting-Ting Jiang; Xiao-Li Liu; Yu-Yong Jiang; Xian-Bo Wang; Zhi-Yun Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-07       Impact factor: 2.629

10.  Normalisation of the psychometric encephalopathy score within the Cameroonian population.

Authors:  Larissa Pessidjo Djomatcho; Mathurin Pierre Kowo; Antonin Ndjitoyap Ndam; Sylvain Raoul Simeni Njonnou; Gabin Ulrich Kenfack; Firmin Ankouane Andoulo; Servais Fiacre Eloumou Bagnaka; Winnie Tatiana Bekolo; Agnès Malongue; Isabelle Dang Babagna; Magloire Biwolé Sida; Henry Luma; Oudou Njoya
Journal:  BMC Gastroenterol       Date:  2021-07-12       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.